Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

January 31, 2001

Study Completion Date

January 31, 2001

Conditions
Hypercalcemia of MalignancyLung CancerMetastatic CancerPainUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

zoledronic acid

PROCEDURE

quality-of-life assessment

Trial Locations (55)

10021

New York Presbyterian Hospital - Cornell Campus, New York

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

11030

North Shore University Hospital, Manhasset

11212

Brookdale University Hospital and Medical Center, Brooklyn

14642

University of Rochester Cancer Center, Rochester

15213

University of Pittsburgh Cancer Institute, Pittsburgh

16505

Regional Cancer Center - Erie, Erie

17033

Milton S. Hershey Medical Center, Hershey

20007

Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington D.C.

21204

Greater Baltimore Medical Center and Cancer Center, Baltimore

24541

Danville Hematology and Oncology, Inc., Danville

27609

Raleigh Internal Medicine, Raleigh

29303

Palmetto Hematology/Oncology Associates, Spartanburg

30338

American Medical Research Institute, Inc., Atlanta

33125

Veterans Affairs Medical Center - Miami, Miami

33176

Oncology-Hematology Group of South Florida, Miami

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

35203

SORRA Research Center, Birmingham

35209

Brookwood ACCC, Birmingham

35294

University of Alabama Comprehensive Cancer Center, Birmingham

37027

Dial Research Associates, Brentwood

38103

Methodist Hospitals of Memphis, Memphis

43235

Hematology Oncology Consultants Inc, Columbus

44195

Cleveland Clinic Cancer Center, Cleveland

48202

Henry Ford Hospital, Detroit

49503

Spectrum Health and DeVos Children's Hospital, Grand Rapids

52242

University of Iowa Hospitals and Clinics, Iowa City

55422

Hubert H. Humphrey Cancer Center, Robbinsdale

55805

St. Mary's/Duluth Clinic Health System, Duluth

62226

Oncology Care Center - Belleville, Belleville

63131

Missouri Baptist Cancer Center, St Louis

64132

Kansas City Internal Medicine, Kansas City

70121

Ochsner Clinic, New Orleans

72764

Highlands Oncology Group, Springdale

73190

University of Oklahoma College of Medicine, Oklahoma City

75710

University of Texas Health Center at Tyler, Tyler

78412

Cancer Specialist of South Texas. P.A., Corpus Christi

80220

Veterans Affairs Medical Center - Denver, Denver

80909

Oncology Clinic, P.C., Colorado Springs

84132

Huntsman Cancer Institute, Salt Lake City

89520

Veterans Affairs Medical Center - Reno, Reno

90073

Veterans Affairs Medical Center - West Los Angeles, Los Angeles

90813

Pacific Shores Medical Group, Long Beach

92064

Southwest Cancer Care, Poway

92270

Cancer and Blood Institute of the Desert, Rancho Mirage

95020

Columbia South Valley Hospital, Gilroy

98104

Swedish Cancer Institute, Seattle

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

46885-5099

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

70502-4016

Louisiana State University Medical Center, Lafayette

71130-3932

Louisiana State University Health Sciences Center - Shreveport, Shreveport

04074

Maine Center for Cancer Medicine and Blood Disorders, Scarborough

02111

New England Medical Center Hospital, Boston

02181

New England Hematology/Oncology Associates, P.C., Wellesley

07018-1095

Veterans Affairs Medical Center - East Orange, East Orange

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY